ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, has launched its highly anticipated LV-2G UNic Early Access Program. This programme marks a significant milestone in lentivirus manufacturing optimization, offering access to groundbreaking vector technology designed to revolutionize viral vector production.
Synexa Life Sciences, a global Clinical Laboratory Services provider for the biopharma industry, has integrated the Olink Target immunoassays and the Olink Signature Q100 instrument into its extensive suite of biomarker discovery platforms.
BBI Solutions OEM Limited (BBI), a leading independent manufacturer of immunodiagnostic reagents, has acquired IBEX Technologies, a leading developer and manufacturer of high-precision enzymes and diagnostic solutions located in Montréal, Canada.
ProBioGen, a global Contract Development & Manufacturing Organization (CDMO), is partnering with DIOSynVax to manufacture DIOS-HFVac3, a trivalent haemorrhagic fever (HF) vaccine that was developed in collaboration with Prof. Dr. Ralf Wagners team at the Institute of Medical Microbiology and Hygiene, University of Regensburg. The novel vaccine targets HF diseases caused by Ebola, Marburg, and […]
A recent breakthrough study from the lab of Tanya Kalin, MD, PhD, professor of Child Health and Internal Medicine at the University of Arizona College of Medicine – Phoenix, has shown potential to improve therapeutic outcomes for patients suffering from lung cancers.
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have successfully grown ‘mini kidneys’ or kidney organoids in the lab and grafted them into live mice, revealing new insights into the metabolic defects and a potential therapy for polycystic kidney disease.
In a groundbreaking move, a panel of leading experts across academia, industry, and government has issued a call to the scientific community to uphold the core values and norms of science amid the revolutionary advances in generative artificial intelligence (AI) through the establishment of a Strategic Council on the Responsible Use of Artificial Intelligence in […]
Researchers from Insilico Medicine and NVIDIA have developed a novel large language model (LLM) called nach0 that can understand and generate both biomedical text and chemical structural data.
A new technique for electrospinning sponges has allowed scientists from the University of Surrey to directly produce 3D scaffolds – on which skin grafts could be grown from the patient’s own skin.
Artificial Intelligence has helped scientists reveal two distinct forms of prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
https://easy-peasy.ai 